fda stops semaglutide for Weight Loss: How It Works, Comparisons, and More FDA-Approved Obesity Medications Timeline: Evolution

Clinical data show that 15.8% of patients taking Ozempic 0.5 mg and 20.3% of patients using Ozempic 1 mg experienced nausea, compared to 6% in the placebo group

This observation aligns with a growing body of evidence suggesting that GLP-1 receptor agonists do far more than regulate blood sugar and appetite

TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway

The term sulfa drug refers to medications with the sulfonamide group within their molecular structure

Lawsuits allege that Novo Nordisk had a legal duty to provide adequate warnings but failed to properly inform consumers of the potential link between Victoza and severe health issues